This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Université´ D'aix-Marseille, Centre Hospitalier Universitaire De Brest. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bohars, FR (2016)
- Brest, FR (2019)
Company Filing History:
2 out of 1,853 
2 out of 237 
1 out of 4 Years Active: 2016-2019
Title: Eric Lemonnier: Innovator in Neurodevelopmental Disorder Treatments
Introduction
Eric Lemonnier is a notable inventor based in Brest, France. He has made significant contributions to the field of neurodevelopmental disorders, particularly in the treatment of Fragile X syndrome and autism. With a total of 2 patents, his work focuses on innovative solutions that address critical health challenges.
Latest Patents
Lemonnier's latest patents include groundbreaking research on modulators of intracellular chloride concentration for treating Fragile X syndrome. This composition aims to provide an effective treatment for individuals suffering from this condition by utilizing a modulator of a chloride transporter. Additionally, he has developed compounds for the treatment of autism, which involve inhibiting the importation of chloride into neurons and improving the outflow of chloride from neurons. These pharmaceutical compositions are designed to enhance treatment options for autism, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Eric Lemonnier has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Aix-Marseille. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his research and innovation capabilities.
Collaborations
Lemonnier has collaborated with notable professionals, including Yehezkel Ben-Ari and Nail Burnashev. These partnerships have contributed to the depth and impact of his research, fostering a collaborative environment that promotes scientific advancement.
Conclusion
Eric Lemonnier's contributions to the treatment of neurodevelopmental disorders through his innovative patents highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile